Literature DB >> 32734337

Management of candiduria in hospitalized patients: a single-center study on the implementation of IDSA guidelines and factors affecting clinical decisions.

Zhengxin He1, Xiaosai Huo1, Daxin Lei1, Huihai Zhao1, Keran Jia1, Fukun Wang2.   

Abstract

Candiduria are common findings in clinic especially in hospitalized patients, while its significance remains undetermined. Since there are few criteria to follow, physicians tended to make decisions by personal experience in many cases in clinical practice. The present study was designed to unveil the present situation of candiduria management in hospitalized patients in clinical practice. A total of 251 hospitalized candiduria patients were retrospectively enrolled in the study. Clinical data on patient demographics, basic conditions, catheter using, urinary symptoms, laboratory data, and antifungal therapies were obtained from electronic medical records. The high rate of the candiduria cases were managed inappropriately after the introduction of the Infectious Diseases Association of America (IDSA) evidence-based recommendations, both in the management of urinary catheter and antifungal agents. Overtreatment was common in asymptomatic candiduria patients. For symptomatic patients, improper drug selections were not rare. In addition, a part of candiduria patients did not receive antifungal therapies although the IDSA recommends. A statistically significant difference was only found in hospital charges of symptomatic candiduria patients managed following IDSA or not. The recurrence rate, mortality, and hospital stay length were similar in candiduria patients regardless of the clinical management. Physicians tend to start empiric antifungal therapy for candiduria patients with pneumonia, multisite of Candida colonization, higher urine Candida CFUs, and long hospital stay. Candiduria has not received special attention today, and empirical antifungal treatment is common. IDSA guidelines are important to standardize the management of candiduria in clinic; however, the significance of the guidelines needs to be further clarified in future multicenter investigations.

Entities:  

Keywords:  Antifungal therapy; Candiduria; Clinical decision; IDSA guidelines; Management

Mesh:

Substances:

Year:  2020        PMID: 32734337     DOI: 10.1007/s10096-020-03999-1

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  32 in total

1.  Candida urinary tract infections--treatment.

Authors:  John F Fisher; Jack D Sobel; Carol A Kauffman; Cheryl A Newman
Journal:  Clin Infect Dis       Date:  2011-05       Impact factor: 9.079

2.  Candida urinary tract infections--epidemiology.

Authors:  Jack D Sobel; John F Fisher; Carol A Kauffman; Cheryl A Newman
Journal:  Clin Infect Dis       Date:  2011-05       Impact factor: 9.079

3.  Association Between Candiduria and Candidemia: A Clinical and Molecular Analysis of Cases.

Authors:  Maria Drogari-Apiranthitou; Ioannis Anyfantis; Irene Galani; Labrini Kanioura; Georgios L Daikos; Georgios Petrikkos
Journal:  Mycopathologia       Date:  2017-07-25       Impact factor: 2.574

Review 4.  Candiduria in intensive care units: association with heavy colonization and candidaemia.

Authors:  S P Toya; D E Schraufnagel; G E Tzelepis
Journal:  J Hosp Infect       Date:  2007-06-18       Impact factor: 3.926

5.  Molecular concordance of concurrent Candida albicans candidemia and candiduria.

Authors:  Po-Yen Huang; Min-Hui Hung; Shian-Sen Shie; Lin-Hui Su; Ke-Yuan Chen; Jung-Jr Ye; Ping-Cheng Chiang; Hsieh-Shong Leu; Ching-Tai Huang
Journal:  Diagn Microbiol Infect Dis       Date:  2013-04-18       Impact factor: 2.803

6.  Effect of body surface decolonisation on bacteriuria and candiduria in intensive care units: an analysis of a cluster-randomised trial.

Authors:  Susan S Huang; Edward Septimus; Mary K Hayden; Ken Kleinman; Jessica Sturtevant; Taliser R Avery; Julia Moody; Jason Hickok; Julie Lankiewicz; Adrijana Gombosev; Rebecca E Kaganov; Katherine Haffenreffer; John A Jernigan; Jonathan B Perlin; Richard Platt; Robert A Weinstein
Journal:  Lancet Infect Dis       Date:  2015-11-27       Impact factor: 25.071

7.  Candidemia and candiduria in critically ill patients admitted to intensive care units in France: incidence, molecular diversity, management and outcome.

Authors:  Marie-Elisabeth Bougnoux; Guillaume Kac; Philippe Aegerter; Christophe d'Enfert; Jean-Yves Fagon
Journal:  Intensive Care Med       Date:  2007-10-02       Impact factor: 17.440

8.  Occurrence of candiduria in a population of chronically catheterized patients with spinal cord injury.

Authors:  L L Goetz; M Howard; D Cipher; S G Revankar
Journal:  Spinal Cord       Date:  2009-07-07       Impact factor: 2.772

9.  Epidemiology and Antifungal Susceptibility of Candida Species Isolated from Urinary Tract Infections: A Study from an Intensive Care Unit of a Tertiary Care Hospital.

Authors:  Priya Datta; Mandeep Kaur; Satinder Gombar; Jagdish Chander
Journal:  Indian J Crit Care Med       Date:  2018-01

10.  Candiduria in hospitalized patients: an investigation with the Sysmex UF-1000i urine analyzer.

Authors:  Zhengxin He; Yanli Liu; Tingting Wang; Yan Cheng; Jing Chen; Fukun Wang
Journal:  PeerJ       Date:  2019-05-20       Impact factor: 2.984

View more
  3 in total

1.  In Vitro Activity of Nitroxoline in Antifungal-Resistant Candida Species Isolated from the Urinary Tract.

Authors:  Frieder Fuchs; Alexander Maximilian Aldejohann; Ada Marie Hoffmann; Grit Walther; Oliver Kurzai; Axel G Hamprecht
Journal:  Antimicrob Agents Chemother       Date:  2022-05-11       Impact factor: 5.938

2.  Polymicrobial Biofilm Dynamics of Multidrug-Resistant Candida albicans and Ampicillin-Resistant Escherichia coli and Antimicrobial Inhibition by Aqueous Garlic Extract.

Authors:  Priya Ashrit; Bindu Sadanandan; Kalidas Shetty; Vijayalakshmi Vaniyamparambath
Journal:  Antibiotics (Basel)       Date:  2022-04-25

3.  Evaluation of a Novel Laboratory Candiduria Screening Protocol in the Intensive Care Unit.

Authors:  Zhengxin He; Chang Su; Yuwang Bi; Yan Cheng; Daxin Lei; Fukun Wang
Journal:  Infect Drug Resist       Date:  2021-02-10       Impact factor: 4.003

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.